Augustine Therapeutics

Augustine Therapeutics

Biotechnology Research Leuven, Vlaams Brabant, Be 24 employees
Employees
24
Contacts
3
Emails
3
Phones
1

Augustine Therapeutics Overview

Headquarters
Leuven, Vlaams Brabant, Be
Website
augustinetx.com
Industry
Biotechnology Research
Employees
24
Founded
2019
Funding
84.1M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Augustine Therapeutics

Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.

Augustine Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Augustine Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Virginie Cartage
Email
Rie Schultz Hansen
View
Pascale Witz Chair, Board Director, Advisor, Former CEO, Investor, Author / Pharma & Biotech, Digital Health, Medtech
Email Phone
Emmanuelle Coutanceau Partner at Novo Holdings
Email

Employees by Management Level

Executive 1 profile
VP / Head 1 profile
Individual contributor 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 1

Compare Similar Companies to Augustine Therapeutics